Frontiers in Oncology

Original Research

Accepted on 28 Apr 2025

Clinicopathological features and risk factors for local recurrence of breast phyllodes tumors: a dual-center, 12-year, retrospective study

in Breast Cancer

Yiwen Li
Heyan Chen
Fengjiang Qu
Xiaoying Qu
Qihe Zhang
Kexuan Feng
Xiaoduo Li
Huimin Zhang
zhimin Fan

Frontiers in Oncology

doi 10.3389/fonc.2025.1538523

Case Report

Accepted on 28 Apr 2025

Locally Invasive Thyroid Metastases from Renal Cell Carcinoma: Surgery after Neoadjvant Therapy

in Surgical Oncology

Dana M. Hartl
Mohamed Amine BANI
Abir Al-Ghuzlan
Andreea-Elena Simonescu
Ingrid Breuskin
Alix Marhic
LAURENCE ALBIGES
Livia Lamartina
Julien Hadoux

Frontiers in Oncology

doi 10.3389/fonc.2025.1543060

Original Research

Accepted on 28 Apr 2025

External validation of the Oncotype DX breast cancer recurrence score nomogram and development and validation of a novel machine learning-based model to predict postoperative overall survival and guide adjuvant chemotherapy in ER positive, Her-2 negative breast cancer patients: a retrospective cohort study

in Breast Cancer

Dongdong Wang
Xinfeng Wang
Xin 杨

Frontiers in Oncology

doi 10.3389/fonc.2025.1586262

Original Research

Accepted on 28 Apr 2025

Comparative Analysis of Multi-zone Peritumoral Radiomics in Breast Cancer for Predicting NAC Response Using ABVS-based Deep Learning Models

in Breast Cancer

Minfang Wang
Wanjun Chen
Ruiping Ren
Yuanwei Lin
Jiawen Tang
Meng Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1586715

Original Research

Accepted on 28 Apr 2025

Impact of Hashimoto's Thyroiditis on Ultrasound Diagnosis of Papillary Thyroid Carcinoma: A Retrospective Study

in Head and Neck Cancer

Chao Teng
Kunkun Pang
Lulu Zhang
Yuan Li
Xiuliang Wei
Feixue Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1551114

Original Research

Accepted on 28 Apr 2025

AMPs inhibit the proliferation, migration, and invasion of lung cancer via the CHRM3/PI3K/AKT and CHRM3/MAPK pathways

in Pharmacology of Anti-Cancer Drugs

Jun Wu
Congcong Huang
Shangning Wang
Liuyan Chen
Quan Cheng
Shao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1582040

Original Research

Accepted on 28 Apr 2025

Habitat-Based Radiomics for Preoperative Differentiation Between Early-Stage Serous Borderline Ovarian Tumors and Malignant Ovarian Tumors

in Gynecological Oncology

Xinping Yu
Yuwei Zou
Chang Wang
Lei Wang
Jinwen Jiao
Haiyang Yu
Shuai Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1559398

Original Research

Accepted on 28 Apr 2025

Innovative Nomogram for Cervical Cancer Prediction: Integrating High-Risk HPV Infection, p53 Genotype, and Blood Routine Parameters

in Gynecological Oncology

Cheng Sun
Jun Zhang
Lili Pan
Shuang Yao
Fenghua Zhang
Linjuan Ji
Miaomei Yu
Guanghua Luo
Xiping Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1541928

Original Research

Accepted on 28 Apr 2025

Unveiling Fatty Acid Subtypes: Immunometabolic Interplay and Therapeutic Opportunities in Gastric Cancer

in Cancer Metabolism

Huahuan Liu
Xin Hu
Xiangnan Zhang
Yanxin Yao
Liuxing Wu
Tian Ye
Hongji Dai
Kexin Chen
Ben Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1570873

Systematic Review

Accepted on 28 Apr 2025

Cumulative temporal association between assisted reproductive technology and childhood cancer: a systematic review and meta-analysis of observational studies

in Pediatric Oncology

Yanjie Jiang
Shipeng Zhang
Hanyu Wang
Xingyi He
Rui Fu
Junwen Tan
Qinwei Fu
Qinxiu Zhang
Yan Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1555420

Systematic Review

Accepted on 28 Apr 2025

Long-term outcomes in patients with endometrial cancer after sentinel lymph node biopsy versus lymphadenectomy alone: a meta-analysis

in Surgical Oncology

Sai Zhang
Juan Zheng
Dandan Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1584447

Original Research

Accepted on 28 Apr 2025

Molecular targets and mechanisms of cortex mori for lung cancer treatment: A network pharmacology study, molecular docking and in vitro and in vivo experimental validation

in Pharmacology of Anti-Cancer Drugs

Ying-Ying Shao
Qiuhong Yang
Shu-Fen He
Han-Bin Zhang
Weichao Han
Baocheng Xie
Ruirong He

Frontiers in Oncology

doi 10.3389/fonc.2025.1587856

Original Research

Accepted on 28 Apr 2025

The prognostic impact of Surufatinib for the treatment of advanced pancreatic ductal adenocarcinoma: A single center real-world retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yanzhen Yang
Qu Xie
Chuankai Shang
Lai Jiang
Guojun Ding
DAN LONG
Cong Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1574934

Original Research

Accepted on 28 Apr 2025

tRF-1:28-Val-CAC-2 promotes the development of nasopharyngeal cancer by targeting EPHB2

in Head and Neck Cancer

Hui Li
Xiaomin Wang
Anchi Sun
Weiwei Liu
Rongrong Lv
Mingjie Zhang
Zhiwei Xing
Shiyin Ma
Yehai Liu
Kai Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1564601

Original Research

Accepted on 28 Apr 2025

Intratumoral CD8+ tumor-infiltrating lymphocytes as prognostic predictors in radio-chemoradiotherapy-treated nasopharyngeal carcinoma

in Head and Neck Cancer

Xinjing Li
Xiaoming Qiu
Cuihong Lin
Yuanying Liu
Yongbin Wang
Langlang Tang
Yuanhe Tong
Linbo Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1551980

Original Research

Accepted on 28 Apr 2025

METTL3-mediated SNHG1 m 6 A modification promotes proliferation and migration by transcriptional regulation of WDR74 in osteosarcoma

in Molecular and Cellular Oncology

Guanzhen Qiu
Yuxin Bao
Yuanzhuang Zhang
Yeqiu Xu
Tianhua Qiao
Chenghao Li
Hanjie Zhai
Zhenjun Chen
Fu Ren
Yong Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1529657